BIBLF yields 3.08% · PFE yields 6.13%● Live data
📍 BIBLF pulled ahead of the other in Year 1
Combined, BIBLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BIBLF + PFE for your $10,000?
Waterloo Brewing Ltd. engages in the production, distribution, and sale of alcohol-based products. It produces, sells, markets, and distributes bottled, canned, and draft premium beer under the Waterloo brand name; and value beer under the Laker and Red Cap brands. The company also produces, sells, and markets vodka-based coolers and ciders under the Seagram trademark; beer under the LandShark brand name; and coolers under the Margaritaville trademark. In addition, it produces, sells, markets, and distributes various beer products under the licensed PC trademark; and produces various products under the No Name brand. Further, the company engages in producing and packaging beer and ready-to-drink alcoholic beverages for other customers. It distributes products to end consumers primarily through grocery stores, The Beer Store in Ontario, and Provincial Liquor Boards in Canada. The company was formerly known as Brick Brewing Co. Limited and changed its name to Waterloo Brewing Ltd. in June 2019. Waterloo Brewing Ltd. was incorporated in 1984 and is headquartered in Kitchener, Ontario.
Full BIBLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.